Sanofi hopes to wield insulin pen in emerging markets

Sanofi India wants to take its Allstar reusable insulin pen into emerging markets in South Asia, Africa and Latin America, executives say. The company launched the pen in India this week, eyeing exports as a next step. Report

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.